|
Issue |
Title |
|
Vol 35, No 3 (2025) |
Possibilities and prospects for the use of telemedicine technologies in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
F. T. Malykhin |
|
Vol 35, No 3 (2025) |
Lymphangioleiomyomatosis, sporadic and associated with tuberous sclerosis: a pulmonologist’s point of view |
Abstract
PDF (Rus)
|
M. A. Makarova, A. S. Belevskiy |
|
Online First |
Asthma and obesity: capabilities of bariatric surgery |
Abstract
PDF (Rus)
|
N. A. Karoli |
|
Vol 35, No 1 (2025) |
The role of the receptor for advanced glycation endproducts (RAGE) in the pathogenesis of asthma |
Abstract
PDF (Rus)
|
L. N. Sorokina, V. N. Mineev, A. S. Pavlova, V. I. Trofimov |
|
Vol 35, No 1 (2025) |
“COPD Navigator” – an innovative tool for doctor and patient |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S N. Feigelman |
|
Vol 34, No 6 (2024) |
Respiratory sarcopenia: aspects of pathogenesis, approaches to diagnosis |
Abstract
PDF (Rus)
|
V. A. Sergeeva, N. K. Runikhina |
|
Vol 34, No 6 (2024) |
“Perplexing” cough |
Abstract
PDF (Rus)
|
I. B. Ponomareva, S. I. Glotov, O. M. Uryasev, S. V. Berstneva, V. A. Lunyakov |
|
Vol 34, No 6 (2024) |
New approaches to the treatment of pulmonary arterial hypertension |
Abstract
PDF (Rus)
|
M. V. Kchachaturov, N. A. Tsareva, S. N. Avdeev |
|
Vol 34, No 6 (2024) |
Biomarkers and genetic predictors of hypersensitivity pneumonitis |
Abstract
PDF (Rus)
|
N. V. Trushenko, A. M. Nikolenko, O. A. Suvorova, S. N. Avdeev |
|
Vol 34, No 5 (2024) |
Prospects of vaccination against pneumococcal infection based on the asthma phenotype |
Abstract
PDF (Rus)
|
A. M. Kostinov, A. Yu. Konishcheva |
|
Vol 34, No 5 (2024) |
Pulmonary hyalinizing granuloma: literature review and case presentation |
Abstract
PDF (Rus)
PDF (Rus)
|
A. V. Bazhenov, A. V. Kochurova, E. M. Petrunina, R. B. Berdnikov, E. A. Ovchinnikova |
|
Vol 34, No 4 (2024) |
Lung cancer and pregnancy |
Abstract
PDF (Rus)
|
A. L. Chernyshova, A. A. Chernyakov, Ju. M. Trushjuk, O. S. Dil, A. E. Chernyshova |
|
Vol 34, No 4 (2024) |
Lung lesions in lymphoproliferative diseases |
Abstract
PDF (Rus)
|
V. V. Gainitdinova, S. N. Avdeev |
|
Vol 34, No 4 (2024) |
Diagnosis and differential diagnosis of focal lung formations |
Abstract
PDF (Rus)
|
I. D. Lagkueva, N. V. Chernichenko, P. M. Kotlyarov, D. G. Soldatov, V. A. Solodkiy |
|
Vol 34, No 3 (2024) |
Use of inhaled nitric oxide in COVID-19 |
Abstract
PDF (Rus)
|
H. C. Nguyen, D. D. Pozdnyakova, I. A. Baranova, A. G. Chuchalin |
|
Vol 34, No 1 (2024) |
The potential use of N-acetylcysteine in respiratory conditions |
Abstract
PDF (Rus)
|
V. N. Antonov, G. L. Ignatova, M. S. Belsner |
|
Vol 33, No 6 (2023) |
Microflora of the lungs in health and disease, the impact of vaccination |
Abstract
PDF (Rus)
|
M. O. Zolotov, A. V. Zhestkov, A. V. Lyamin, V. D. Fedotov |
|
Vol 33, No 6 (2023) |
Oscillometry: clinical significance and applications |
Abstract
PDF (Rus)
|
L. D. Kiryukhina, A. V. Chernyak |
|
Vol 33, No 6 (2023) |
Pulmonary hemorrhage in cystic fibrosis: a review of current data |
Abstract
PDF (Rus)
|
M. M. Fedotova, A. A. Doronina |
|
Vol 33, No 6 (2023) |
Tiotropium bromide in the treatment of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
O. N. Titova, N. A. Kuzubova, A. G. Kozyrev |
|
Vol 34, No 1 (2024) |
“Ground glass opacity” sign in lung diseases: nuances of radiological diagnosis and correct interpretation |
Abstract
PDF (Rus)
|
A. A. Karpova, N. I. Sergeev, P. A. Nikitin, V. A. Solodkiy, P. M. Kotlyarov, N. V. Nudnov, Z. S. Tsallagova, D. G. Soldatov |
|
Vol 34, No 1 (2024) |
Influence of adipocytokines on the bronchopulmonary system in abdominal obesity |
Abstract
PDF (Rus)
|
A. D. Khudiakova, Yu. I. Ragino |
|
Vol 33, No 5 (2023) |
Pulmonary sequestrations |
Abstract
PDF (Rus)
|
A. V. Bazhenov, I. Ya. Motus, R. B. Berdnikov, A. S. Romahin |
|
Vol 33, No 5 (2023) |
Significance of N-acetylcysteine in clinical practice |
Abstract
PDF (Rus)
|
I. V. Leshchenko, N. A. Esaulova |
|
Vol 33, No 4 (2023) |
The role of metabolic syndrome factors in the pathogenesis of respiratory disorders |
Abstract
PDF (Rus)
|
O. V. Voronkova, Yu. G. Birulina, T. V. Saprina, I. E. Esimova, I. A. Osikhov |
|
Vol 33, No 4 (2023) |
Skin test based on Mycobacterium tuberculosis antigens (ESAT-6 and CFP-10) for the detection of tuberculosis infection in world practice |
Abstract
PDF (Rus)
|
O. E. Russkikh, E. V. Savintseva, D. A. Kudlay, N. P. Doktorova, P. G. Sysoev |
|
Vol 33, No 3 (2023) |
Eosinophilic granulomatosis with polyangiitis: etiopathogenesis, classification and clinical phenotypes |
Abstract
PDF (Rus)
|
E. Kh. Anaev, A. S. Belevskiy, N. P. Kniajeskaia |
|
Vol 33, No 3 (2023) |
Clinical significance of club cell protein CC16 in respiratory medicine |
Abstract
PDF (Rus)
|
M. M. Shapovalova, S. N. Avdeev, A. V. Budnevsky, L. V. Tribuntseva |
|
Vol 33, No 3 (2023) |
Psychosomatic functional disorders in pulmonary practice |
Abstract
PDF (Rus)
|
S. I. Ovcharenko, D. V. Troshina, P. S. Sokolova, B. A. Volel |
|
Vol 33, No 2 (2023) |
Ciliated cell cultures for diagnosis of primary ciliary dyskinesia |
Abstract
PDF (Rus)
|
A. G. Demchenko, S. A. Smirnikhina |
|
Vol 33, No 2 (2023) |
Randu - Osler - Weber disease (or hereditary hemorrhagic teleangectasia) with respiratory involvement |
Abstract
PDF (Rus)
|
Yu. L. Mizernitskiy, P. A. Shatokha, L. V. Sokolova |
|
Vol 33, No 2 (2023) |
Potential predictors of severe course and outcome of community-acquired pneumonia |
Abstract
PDF (Rus)
|
E. V. Volchkova, O. N. Titova, N. A. Kuzubova, E. S. Lebedeva |
|
Vol 33, No 1 (2023) |
Cellular metabolism and mitochondrial dysfunction in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
V. A. Nevzorova, T. A. Brodskaya, N. G. Plekhova, L. G. Priseko, A. A. Evstifeeva, A. E. Bagirova |
|
Vol 33, No 1 (2023) |
Treatment, diagnostics, and management of chronic obstructive pulmonary disease in women |
Abstract
PDF (Rus)
|
F. T. Malykhin, V. A. Baturin |
|
Vol 33, No 1 (2023) |
Improving the effectiveness of vaccination against viral and bacterial pathogens through micronutrient supplementation |
Abstract
PDF (Rus)
|
I. Yu. Torshin, O. A. Gromova, V. A. Maksimov, A. G. Chuchalin |
|
Vol 33, No 5 (2023) |
Differential diagnosis of community-acquired pneumonia and lung damage in respiratory viral infections, including COVID-19 |
Abstract
PDF (Rus)
|
D. A. Strelkova, A. A. Irgiskin, S. A. Rachina |
|
Vol 32, No 6 (2022) |
Bilateral pleural effusion: etiology, diagnostics |
Abstract
PDF (Rus)
|
N. A. Stogova |
|
Vol 32, No 6 (2022) |
D-hypovitaminosis in working age patients with diseases of the respiratory organs: the risks and prevention |
Abstract
PDF (Rus)
|
L. K. Ibrayeva, D. Kh. Rybalkina, O. A. Evmenova, F. M. Turdaly, Zh. T. Ibragim |
|
Vol 32, No 6 (2022) |
The upper respiratory tract microbiome and its role in human health: barrier function |
Abstract
PDF (Rus)
|
E. V. Starikova, Yu. S. Galeeva, E. N. Il’ina |
|
Vol 34, No 1 (2024) |
The role of mast cells in the pathogenesis of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, I. A. Savushkina, Ya. S. Shkatova, V. V. Shishkina |
|
Vol 34, No 1 (2024) |
Various approaches to improving adherence of patients with tuberculosis. Prospects for the use of additive technologies in TB practice |
Abstract
PDF (Rus)
|
A. G. Naumov, A. S. Shprykov |
|
Vol 33, No 5 (2023) |
Gut–lung axis |
Abstract
PDF (Rus)
|
V. S. Belyaev, V. M. Chervinets, Yu. V. Chervinets |
|
Vol 33, No 4 (2023) |
The current status of antimicrobial resistance of Streptococcus pneumoniae and specific vaccine prevention of pneumococcal infection |
Abstract
PDF (Rus)
|
A. A. Kurkova, A. A. Muraviov, R. S. Kozlov |
|
Vol 33, No 4 (2023) |
Eosinophilic granulomatosis with polyangiitis: diagnosis and treatment-related issues |
Abstract
PDF (Rus)
|
E. Kh. Anaev, N. P. Kniajeskaia |
|
No 4 (2001) |
Pleurisy in lung carcinoma |
Abstract
PDF (Rus)
|
A. L. Akopov |
|
No 4 (2001) |
To a problem of radiation-induced lung carcinoma |
Abstract
PDF (Rus)
|
A. E. Ali-Risa, M. V. Samsonova |
|
No 4 (2001) |
Short-acting ß2-agonists. Their influence on bronchial asthma course and mortality |
Abstract
PDF (Rus)
|
F. I. Petrovsky |
|
No 4 (2001) |
Community-acquired pneumonia in elderly patients. Strategy and tactics of antibacterial therapy |
Abstract
PDF (Rus)
|
L. I. Dvoretsky |
|
No 4 (2001) |
Clinical efficiency of formoterol when there is no response to salmeterol |
Abstract
PDF (Rus)
|
J. Kottakis, R. Woods, V. Le Gross, G. Della Cioppa |
|
No 3 (2001) |
Problems and achievements of gene therapy of cystic fibrosis |
Abstract
PDF (Rus)
|
P. S. Baranov, T. E. Ivashchenko, N. B. Glazkov |
|
No 3 (2001) |
Application of Levofloxacin in pulmonology |
Abstract
PDF (Rus)
|
S. V. Yakovlev, V. P. Yakovlev |
|
No 3 (2001) |
Optimal management of adult cystic fibrosis patients in an outpatient department |
Abstract
PDF (Rus)
|
L. A. Kronina, V. A. Samoilenko |
|
No 3 (2001) |
Intensive care for adult cystic fibrosis patients |
Abstract
PDF (Rus)
|
S. N. Avdeev, V. A. Samoilenko, E. L. Amelina, A. G. Chuchalin |
|
No 3 (2001) |
A role and a site of a combined therapy with Seretid (salmeterol/fluticazone propionate) in bronchial asthma treatment (review) |
Abstract
PDF (Rus)
|
V. l. Petrov, I. V. Smolenov, N. A. Smirnov |
|
No 2 (2001) |
Berotec H is a new form of non-freon metered dose inhaler |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, I. L. Klyachkina |
|
No 2 (2001) |
AIDS, narcotic dependence and maternity |
Abstract
PDF (Rus)
|
K. I. Volkova, A. N. Kokosov |
|
No 1 (2001) |
An application of severity assessment scores in intensive therapy and pulmonology |
Abstract
PDF (Rus)
|
S. N. Avdeev, A. G. Chuchalin |
|
No 1 (2001) |
Lung diseases in the Great Patriotic War (using Soviet medicine data from the period of the Great Patriotic War, 1941-1945) |
Abstract
PDF (Rus)
|
E. Yu. Zhavoronkova |
|
No 1 (2001) |
Difficult asthma |
Abstract
PDF (Rus)
|
L. M. Ogorodova, F. I. Petrovsky, Yu. I. Petrovskaya, O. S. Kobyakova |
|
No 1 (2001) |
Fenspirid (Erespal) in a treatment of pulmonary obstructive diseases |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 3 (2000) |
Biology of alveolocytes type II isolated from lung and cultured in vitro. 2. Morphological-and-functional peculiarities of isolated alveolocytes type II. |
Abstract
PDF (Rus)
|
L. K. Romanova |
|
No 3 (2000) |
Population-and-genetic approach to prognosing of diabetes development in oronchial asthma patients |
Abstract
PDF (Rus)
|
G. Yu. Babadzhanova |
|
No 2 (2000) |
New abilities of anti-histamine drugs |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 2 (2000) |
Tailed in bronchial asthma pharmacological management |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 1 (2000) |
Fixed combinations of inhaled steroids and long-acting β2-agonists in bronchial asthma treatment |
Abstract
PDF (Rus)
|
A. G. Chuchalin, E. N. Kalmanova, Z. R. Aisanov, O. Yu. Stoulova, M. V. Beda |
|
No 4 (1999) |
Diagnostic value of computed and magnetic resonance tomography in pathology of lungs and mediastinum |
Abstract
PDF (Rus)
|
P. M. Kotlyarov, N. K. Sviridov, N. L. Shitnanovsky |
|
No 4 (1999) |
The role of Oxis Turbuhaler (Formoterol) in bronchial asthma therapy |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov |
|
No 4 (1999) |
Modern laboratory diagnostics of the respiratory tuberculosis |
Abstract
PDF (Rus)
|
V. I. Golyshevskaya, L. N. Chernousova, Ye. F. Shashkina, O. O. Kovalenko, Ye. Ye. Larionava |
|
No 2 (1999) |
Pharmacokinetik parameters of modern inhaled glucocorticoids |
Abstract
PDF (Rus)
|
A. N. Tsoy |
|
No 2 (1999) |
Formation and role of biological defects for bronchial asthma appearance and development |
Abstract
PDF (Rus)
|
V. I. Nemtsov, G. B. Fedoseev |
|
No 2 (1999) |
Use of quinolones for treatment of in-patient and out-patient pneumonias |
Abstract
PDF (Rus)
|
Yu. B. Belousov, Zh. A. Galeeva, O. V. Efremenkova |
|
No 1 (1999) |
Intracellular signal systems and lung pathology. Ion transport in airway epithelium cells |
Abstract
PDF (Rus)
|
S. N. Orlov, I. A. Baranova, A. G. Chuchalin |
|
No 1 (1999) |
Systems for drugs delivery to airways by inhalation |
Abstract
PDF (Rus)
|
L. M. Ogorodova |
|
No 4 (1998) |
Biopsy in pulmonology |
Abstract
PDF (Rus)
|
I. Ya. Motus |
|
No 4 (1998) |
Preoperative monitoring of the external respiration function and reserves in lung surgery |
Abstract
PDF (Rus)
|
L. K. Bronskaya, A. Ya. Samokhin, V. S. Sokolova, M. I. Chushkin |
|
No 4 (1998) |
Is the Deflatsacort a sintetic glucocorticoid with the less side effects? |
Abstract
PDF (Rus)
|
G. Yu. Babadzhanova, A. G. Chuchalin, B. Allolio |
|
No 2 (1998) |
Life quality of patients with chronic obstructive pulmonary diseases |
Abstract
PDF (Rus)
|
E. I. Shmelev, M. V. Beda, Paul W. Sones, Rob Thwaites, A. G. Thwaites |
|
No 2 (1998) |
Induced sputum method in evaluation of airway inflammatory intensity |
Abstract
PDF (Rus)
|
S. N. Avdeev, E. Kh. Anaev, A. G. Chuchalin |
|
No 1 (1998) |
Leucotriene antagonists and inhibitors in bronchial asthma treatment |
Abstract
PDF (Rus)
|
V. L. Kovaleva, A. G. Chuchalin, N. A. Kolganova |
|
No 1 (1998) |
Aldecid in bronchial asthma treatment |
Abstract
PDF (Rus)
|
I. M. Kakhnovsky, V. F. Marinin, S. V. Arkhipova, L. A. Sorokina |
|
No 4 (1997) |
The Pathogenesis of Pneumoconiosis: Contemporary Ideas and a Retrospect |
Abstract
PDF (Rus)
|
Y. A. Loschilov |
|
No 4 (1997) |
AIDS: Pneumocystal Pneumonia |
Abstract
PDF (Rus)
|
K. I. Volkova, A. N. Kokosova |
|
No 3 (1997) |
Advantages and disadvantages of appliances for individual inhalation therapy |
Abstract
PDF (Rus)
|
A. N. Tsoi |
|
No 3 (1997) |
Immunopathology molecular and cellular mechanisms for bronchial asthma patients |
Abstract
PDF (Rus)
|
M. P. Potapnev, D. V. Pechkovsky |
|
No 3 (1997) |
Respiratory effects of ozone |
Abstract
PDF (Rus)
|
S. O. Aleinikov, A. G. Chuchalin |
|
No 2 (1997) |
Nitric oxide and lung hemocirculation |
Abstract
PDF (Rus)
|
V. A. Nevzorova, B. I. Geltser |
|
No 2 (1997) |
Treatment for a sleep apnea syndrome with the constant positive pressure in respioratory tracts |
Abstract
PDF (Rus)
|
S. L. Babak, A. M. Belov, R. V. Buzunov, R. A. Grigoriants, L. I. Kozlova, S. V. Stebletsov, A. G. Chuchalin |
|
No 4 (1995) |
Inhalational glucocorticoids in broncial asthma therapy |
Abstract
PDF (Rus)
|
O. A. Sutochnikova, A. L. Cherniayev, A. G. Chuchalin |
|
No 4 (1995) |
Pulmonary hemodynamics in patients with sleep apnea syndrome |
Abstract
PDF (Rus)
|
A. D. Palman, T. S. Eligulashvili |
|
No 2 (1995) |
Intracellular signaling systems and pulmonary pathology. I. Smooth muscle cells |
Abstract
PDF (Rus)
|
S. N. Orlov, I. A. Baranova, A. G. Chuchalin |
|
No 2 (1995) |
Respiratory supairments in prematurely born infants |
Abstract
PDF (Rus)
|
V. N. Suchkova, M. G. Viaskova |
|
No 1 (1995) |
The free radical reaction development in pulmonary cells during asbestos influence (rewiew) |
Abstract
PDF (Rus)
|
S. K. Sohodajeva |
|
No 1 (1995) |
The study of antioxidant activity of biological and pharmacologic aspects |
Abstract
PDF (Rus)
|
E. S. Dremina, V. S. Sharov, Y. A. Vladimirov |
|
No 4 (1994) |
The tests of the specific bronchial challenge in the bronchial asthma diagnostics |
Abstract
PDF (Rus)
|
D. G. Soldatov, I. A. Kusakina, E. V. Babarskov |
|
No 4 (1994) |
Specific immune therapy of bronchial asthma |
Abstract
PDF (Rus)
|
D. S. Nugmanova |
|
No 4 (1994) |
The structural-functional characteristics of eosynophils and their role in the bronchial asthma pathogenesis and treatment |
Abstract
PDF (Rus)
|
E. H. Anaev, A. L. Cherniaev, A. R. Tatarskiy, L. M. Voronina |
|
No 3 (1994) |
Cystic fibrosis in adults: ethyology, pathogenesis, perspectives of treatment |
Abstract
PDF (Rus)
|
A. G. Chuchalin, L. M. Voronina, L. A. Kronina, M. V. Samsonova |
|
No 3 (1994) |
Moder approaches to treatment of infectional process during cystic fibrosis (Review) |
Abstract
PDF (Rus)
|
L. A. Jelenina, T. E. Gembitskaya |
|
No 3 (1994) |
Antimicrobic therapy during cystic fibrosis in infants |
Abstract
PDF (Rus)
|
L. A. Shabalova |
|
No 2 (1994) |
Respiration function and blood gas content during heart rhythm and conductivity impairments |
Abstract
PDF (Rus)
|
I. V. Maev, E. V. Filippova |
|
No 2 (1994) |
Hypersencitivity and hyperreactivity of cholinergic bronchial receptors and nonspecific pulmonary diseases |
Abstract
PDF (Rus)
|
D. A. Shikhnebiev |
|
No 1 (1994) |
The prevalence of chronic bronchitis and bronchial asthma (data of epydemiological studies) |
Abstract
PDF (Rus)
|
T. N. Bilichenko |
|
No 1 (1994) |
Some aspects of physiologic and toxic effects of hyperoxia |
Abstract
PDF (Rus)
|
R. S. Vinitskaia, O. V. Alexandrov, G. V. Nekliudova, J. K. Naumenko |
|
No 5 (2004) |
Field evaluation of dyspnea and functional status in respiratory pathology (review) |
Abstract
PDF (Rus)
|
S. Yu. Chikina |
|
No 5 (2003) |
A Influence of Spiriva on lung function parameters: clinical research data |
Abstract
PDF (Rus)
|
Z. R. Aisanov |
|
No 1 (2003) |
To medication influence on dyspnoe |
Abstract
PDF (Rus)
|
V. N. Abrosimov, A. V. Shutov |
|
No 3 (2002) |
Foradil (formoterol fumarate): a significance and a place in the therapy of asthma and COPD |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 32, No 5 (2022) |
Chronic obstructive pulmonary disease and COVID-19 |
Abstract
PDF (Rus)
|
E. A. Zaryanova, G. L. Osipova, V. V. Osipova |
|
No 1 (1991) |
Methodology of pneumonia studies (the experience of two centuries) |
Abstract
PDF (Rus)
|
B. M. Ariel, Yu. A. Barshtein |
|
No 1 (2013) |
Langerhans' cell histiocytosis |
Abstract
PDF (Rus)
|
K. S. Voitkovskaya, A. L. Chernyaev |
|
No 2 (2013) |
The role of viruses in the development of bronchopulmonary diseases |
Abstract
PDF (Rus)
|
L. G. Simonyan |
|
No 5 (2013) |
Reasonability and perspectives of anti-cytokine and immune correcting therapy in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. G. Kadushkin, A. D. Taganovich, N. D. Taganovich |
|
No 2 (2014) |
|
Details
PDF (Rus)
|
S. N. Avdeev |
|
No 4 (2014) |
Diagnostic values of biomarkers in acute exacerbation of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. V. Budnevskiy, E. S. Ovsyannikov, A. V. Chernov, E. S. Drobysheva |
|
Vol 25, No 1 (2015) |
Immunomodulating therapy and respiratory viral infections: an immunologist's point of view |
Abstract
PDF (Rus)
|
A. V. Karaulov |
|
Vol 26, No 1 (2016) |
Vilanterol / umeclidinium bromide combination as a basic therapy for chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
S. Yu. Chikina |
|
Vol 26, No 5 (2016) |
MAXIMAL BRONCHODILATION WITH STARTING THERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN INFLUENCE ON THE COURSE OF THE DISEASE |
Abstract
PDF (Rus)
|
S. N. Avdeev, Z. R. Aisanov |
|
Vol 27, No 2 (2017) |
GOLD 2017: what change were made in global strategy of treatment of chronic obstructive pulmonary disease and why? |
Abstract
PDF (Rus)
|
E. N. Barabanova |
|
Vol 28, No 2 (2018) |
Magnetic resonance imaging for diagnostics of lung diseases |
Abstract
PDF (Rus)
|
P. M. Kotlyarov, I. D. Lagkuyeva, N. I. Sergeyev, V. A. Solodkiy |
|
Vol 29, No 1 (2019) |
Immunoglobulin G4-related lung disease |
Abstract
PDF (Rus)
|
M. Yu. Brovko, L. A. Akulkina, V. I. Sholomova, L. Frantsuzevich, A. S. Tertychnyy, A. Sh. Yanakaeva, D. V. Konovalov, A. I. Grishkovets, S. V. Moiseev |
|
Vol 29, No 6 (2019) |
The age-related assessment of pulmonary function in children with cystic fibrosis aged below 6 years |
Abstract
PDF (Rus)
|
E. G. Furman, E. I. Kondrat'eva, A. V. Chernyak, V. V. Shadrina |
|
No 6 (2010) |
Стероидозависимая бронхиальная астма: рекомендации по ведению пациентов и снижению дозы системных глюкокортикостероидов |
Details
PDF (Rus)
|
, |
|
No 5 (2008) |
Respiratory infections and asthma |
Abstract
PDF (Rus)
|
G. E. Khaptkhaeva, A. G. Chuchalin |
|
No 3 (2007) |
Alfa-1-antitripsin deficiency and chronic obstrictive pulmonary disease |
Abstract
PDF (Rus)
|
A. V. Averyanov, A. E. Polivanova |
|
No 6 (2007) |
Substantiation and approaches to rehabilitation of patients with chronic respiratory diseases |
Abstract
PDF (Rus)
|
N. S. Ayrapetova, M. A. Rassulova, A. N. Razumov |
|
Vol 30, No 6 (2020) |
Disease-modifying treatment of asthma: role of omalizumab |
Abstract
PDF (Rus)
|
G. A. Novik, S. N. Avdeev, Yu. V. Solovkina |
|
No 6 (2004) |
Achieving asthma control with flexible dosing of Simbicort in moderate to severe bronchial asthma patients. Findings of SUND study. |
Abstract
PDF (Rus)
|
N. P. Knyazheskaya, M. O. Potapova |
|
No 5 (2003) |
Modern theories of polypous rhinosinusitis pathogenesis |
Abstract
PDF (Rus)
|
A. S. Lopatin |
|
No 1 (2003) |
Molecular basis and clinical aspects of alfa 1 -antitripsin deficiency |
Abstract
PDF (Rus)
|
V. P. Pusyrev, V. Ya. Savyuk |
|
No 3 (2002) |
Moxifloxacine in the treatment of severe community-acquired pneumonia: is it the first opportunity for monotherapy? |
Abstract
PDF (Rus)
|
S. V. Yakovlev |
|
No 2 (1991) |
The plateletes: physiological activity. Their pathogenetic role in bronchial asthma |
Abstract
PDF (Rus)
|
A. R. Tatarsky, K. M. Alieva |
|
No 1 (2013) |
Pulmonary lesions due to drug therapy of Hodgkin's lymphoma |
Abstract
PDF (Rus)
|
A. A. Danilenko, S. V. Shakhtarina |
|
No 2 (2013) |
Multi-drug resistant tuberculosis and HIV-infection |
Abstract
PDF (Rus)
|
V. S. Borovitsky |
|
No 5 (2013) |
New abilities of administration of tiotropium bromide using the aerosol delivery device Respimat® |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 2 (2014) |
LEUKOTRIENE RECEPTOR ANTAGONISTS IN DIFFERENT PHENOTYPES OF BRONCHIAL ASTHMA |
Abstract
PDF (Rus)
|
N. P. Knyazheskaya |
|
No 4 (2014) |
Antibacterial treatment of moderate chronic obstructive pulmonary disease exacerbation |
Abstract
PDF (Rus)
|
V. A. Kazantsev, I. A. Guchev |
|
Vol 25, No 2 (2015) |
Current opportunities of endovascular diagnosis and treatment of pulmonary hemorrhage |
Abstract
PDF (Rus)
|
V. N. Yakovlev, E. R. Khayrutdinov, A. V. Arablinskiy, V. G. Alekseev |
|
Vol 26, No 1 (2016) |
Riociguat and sildenafil for pulmonary hypertension: similarity and difference |
Abstract
PDF (Rus)
|
A. A. Shmal'ts, S. V. Gorbachevskiy |
|
Vol 26, No 5 (2016) |
PATHOGENIC PARTICULARITIES OF CARDIOVASCULAR CONTINUUM IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Abstract
PDF (Rus)
|
N. T. Vatutin, A. S. Smirnova, D. V. Bort, G. G. Taradin |
|
Vol 27, No 3 (2017) |
Three-component model of pulmonary mechanical activity |
Abstract
PDF (Rus)
|
Fedor F. Tetenev, Konstantin F. Tetenev, Tat'yana S. Ageeva, Tamara N. Bodrova, Aleksandr I. Karzilov, Pavel E. Mes’ko, Anna V. Teteneva |
|
Vol 28, No 2 (2018) |
Effects of fixed combination of indacaterol/glycopyrronium in chronic obstructive pulmonary disease: state-of-the art review |
Abstract
PDF (Rus)
|
S. N. Avdeev, N. V. Trushenko |
|
Vol 29, No 1 (2019) |
Musculoskeletal disorders in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. K. Suleymanova, I. A. Baranova |
|
Vol 30, No 1 (2020) |
Interstitial lung lesion in systemic scleroderma (literature review and personal observation) |
Abstract
PDF (Rus)
|
M. S. Nashatyreva, I. N. Trofimenko, B. A. Chernyak |
|
No 6 (2010) |
Современные аспекты эпидемиологии саркоидоза |
Details
PDF (Rus)
|
, |
|
No 5 (2008) |
Emphysema and air cysts of the lung |
Abstract
PDF (Rus)
|
A. S. Filatova, L. M. Grinberg |
|
No 3 (2007) |
Safety of long-acting β2-agonists in asthma |
Abstract
PDF (Rus)
|
S. N. Avdeev, L. M. Ogorodova, E. S. Kulikov |
|
No 1 (2005) |
Флуоресцентная диагностика раннего центрального рака легкого |
Abstract
PDF (Rus)
|
, , , , , , |
|
Vol 30, No 6 (2020) |
Cavity forms of thoracic sarcoidosis (literature review, clinical and radiological observations) |
Abstract
PDF (Rus)
|
A. V. Lenshin, A. V. Il'in, Yu. M. Perelman |
|
No 5 (2004) |
Efficacy and safety of ultra-fine dispersed beclomethasone dipropionate in bronchial asthma patients (review) |
Abstract
PDF (Rus)
|
A. V. Emelyanov |
|
No 5 (2003) |
Foradil in therapy of COPD: results of clinical trials |
Abstract
PDF (Rus)
|
E. N. Kalmanova, Z. R. Aisanov |
|
No 2 (2003) |
Role of combined therapy with β2-agonists and anticholinergic drugs in bronchial asthma |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 5 (2002) |
Bronchial asthma and coexisting digestive diseases |
Abstract
PDF (Rus)
|
D. I. Korabelnikov, A. G. Chuchalin |
|
No 3 (1991) |
Legionellesis – epidemiology, clinics, diagnoctics, and treatment |
Abstract
PDF (Rus)
|
V. T. Ivashkin, A. I. Sinopalnikov, V. S. Kabanov, V. A. Baikov, O. I. Klochkov, A. A. Budko |
|
No 1 (2012) |
A role of peroxiredoxins in oxidative stress in the respiratory system |
Abstract
PDF (Rus)
|
V. I. Novoselov |
|
No 1 (2013) |
Investigation of nutritional status and body composition in patients with tuberculosis |
Abstract
PDF (Rus)
|
S. G. Rudnev, G. N. Mozhokina, E. M. Bogorodskaya, N. E. Galygina, D. V. Nikolaev, O. E. Russkikh |
|
No 2 (2013) |
A role of inertial mechanism for clearance of aerosol particle from the lung |
Abstract
PDF (Rus)
|
G. V. Fedorovich |
|
No 5 (2013) |
Current view on a role of CD38 for pathogenesis of bronchial asthma |
Abstract
PDF (Rus)
|
I. A. Solovyeva, E. A. Sobko, A. Yu. Kraposhina, I. V. Demko, A. B. Salmina |
|
No 4 (2011) |
About the genetics of pulmonary emphysema |
Abstract
PDF (Rus)
|
T. V. Ivchik |
|
No 4 (2014) |
Efficacy of tiotropium bromide in patients with bronchial asthma |
Abstract
PDF (Rus)
|
A. F. Ivanov, B. A. Chernjak |
|
Vol 25, No 2 (2015) |
Chronic cough hypersensitivity syndrome |
Abstract
PDF (Rus)
|
S. Yu. Chikina |
|
Vol 26, No 1 (2016) |
Ghrelin signaling pathway in bronchial asthma |
Abstract
PDF (Rus)
|
V. N. Mineev, T. M. Lalaeva, A. A. Lebedeva |
|
Vol 26, No 6 (2016) |
Pulmonary hypertension in sarcoidosis |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 27, No 3 (2017) |
About a role of particle pollution for pathogenesis of chronic lung diseases |
Abstract
PDF (Rus)
|
Alla F. Kolpakova, Ruslan N. Sharipov, Fedor A. Kolpakov |
|
Vol 28, No 2 (2018) |
Chronic obstructive pulmonary disease: mono-, double-, triple therapy… |
Abstract
PDF (Rus)
|
K. A. Zykov, A. V. Rvacheva, V. I. Kobylyanskiy, G. L. Osipova, A. R. Tatarskiy, E. I. Sokolov |
|
Vol 29, No 2 (2019) |
Triple therapy in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
Sergey N. Avdeev, Natal’ya V. Trushenko |
|
Vol 30, No 1 (2020) |
Modern approaches to the management of patients with bronchoectasia |
Abstract
PDF (Rus)
|
E. Kh. Anaev |
|
No 6 (2010) |
Ингаляционные глюкокортикостероиды при хронической обструктивной болезни легких |
Details
PDF (Rus)
|
|
|
No 5 (2008) |
Bronchial asthma and respiratory tract infection: diagnosis and treatment |
Abstract
PDF (Rus)
|
G. B. Fedoseev, V. I. Trofimov, E. I. Rovkina, V. K. Yakovleva |
|
No 4 (2007) |
Primary ciliary dyskinesia as a genetic pathology |
Abstract
PDF (Rus)
|
A. E. Bogorad, N. N. Rozinova |
|
No 2 (2005) |
Idiopathic interstitial pneumonia in adults and children (review) |
Abstract
PDF (Rus)
|
Yu. A. Tereshchenko, S. Yu. Tereshchenko, M. V. Vlasova |
|
Vol 31, No 1 (2021) |
Hypersensitivity pneumonitis |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 5 (2004) |
Inhaled steroids in stable chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, I. L. Klyachkina |
|
No 5 (2003) |
Erespal (fenspirid) in therapy of respiratory diseases |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 2 (2003) |
Severe community-acquired pneumonia. Modern opportunities of antimicrobial therapy |
Abstract
PDF (Rus)
|
L. I. Dvoretsky |
|
No 5 (2002) |
An assessment of cost-effectiveness of outpatients therapy for bronchial asthma or obstructive bronchitis exacerbation in children |
Abstract
PDF (Rus)
|
A. B. Malakhov, N. A. Geppe, A. V. Karpushkina, T. A. Belova, T. G. Reshetova, M. A. Malakhov, S. P. Mairko |
|
Vol 32, No 1 (2022) |
Lung auscultation: Pathogenic mechanisms underlying the respiratory sounds |
Abstract
PDF (Rus)
|
G. P. Arutyunov, E. A. Kolesnikova, D. V. Polyakov, A. K. Rylova, M I. Korsunskaya |
|
No 4 (1991) |
Free radical oxygenation in the pathogenesis of respiratory diseases |
Abstract
PDF (Rus)
|
Yu. M. Goldenberg, A. N. Kokosov, V. P. Mishchenko, I. V. Redtsits |
|
No 1 (2012) |
Chronic pulmonary hypertension and nitric oxide |
Abstract
PDF (Rus)
|
Kh. M. Markov |
|
No 3 (2012) |
Relationships of asthma and obesity |
Abstract
PDF (Rus)
|
L. N. Pristupa, A. A. Fadeeva |
|
No 1 (2014) |
A ROLE OF EPIDEMIOLOGICAL STUDIES IN PULMONOLOGY |
Abstract
PDF (Rus)
|
V. V. Arkhipov, D. E. Arkhipova |
|
No 5 (2013) |
A role of combined therapy with M-cholinolytic and β2-adrenomimetic drugs for bronchial obstruction |
Abstract
PDF (Rus)
|
A. A. Visel, I. Yu. Visel |
|
No 4 (2011) |
Arterial wall stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
M. A. Makarova, S. N. Avdeev |
|
No 4 (2014) |
Therapeutic perspectives of recurrent respiratory infections |
Abstract
PDF (Rus)
|
V. A. Isakov, D. V. Isakov |
|
Vol 25, No 3 (2015) |
From high-quality spirometry to optimal bronchodilator therapy (analytical review) |
Abstract
PDF (Rus)
|
A. A. Vizel', I. Yu. Vizel' |
|
Vol 26, No 1 (2016) |
Influenza vaccination in pregnancy: unresolved issues |
Abstract
PDF (Rus)
|
D. V. Pakhomov, M. P. Kostinov, E. A. Khromova, S. S. Semenova |
|
Vol 26, No 6 (2016) |
Molecular mechanisms of corticosteroid resistance in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. G. Kadushkin, A. D. Taganovich |
|
Vol 27, No 4 (2017) |
New abilities in therapy of idiopathic pulmonary fibrosis |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 28, No 3 (2018) |
Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation |
Abstract
PDF (Rus)
|
S. N. Avdeev, N. M. Nenasheva, K. V. Zhudenkov, V. A. Petrakovskaya, G. V. Izyumova |
|
Vol 29, No 2 (2019) |
Current data on improvement in physical tolerance and a role of physical activity in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
Zaurbek R. Aisanov, Yuliya G. Belotserkovskaya, Sergey N. Avdeev, Andrey S. Belevskiy |
|
Vol 30, No 1 (2020) |
Perfusion computer tomography in clarifying the nature of pathological processes in the lung |
Abstract
PDF (Rus)
|
I. D. Lagkueva, P. M. Kotlyarov, N. I. Sergeev, V. A. Solodkiy |
|
No 6 (2010) |
Хроническая обструктивная болезнь легких и хроническая сердечная недостаточность: особенности совместной терапии |
Details
PDF (Rus)
|
|
|
No 5 (2008) |
About administration of nebulised suspension of budesonide on exacerbation of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
I. V. Leshchenko |
|
No 4 (2007) |
Bronchopulmonary dysplasia |
Abstract
PDF (Rus)
|
D. Yu. Ovsyannikov, L. G. Kuzmenko |
|
No 3 (2005) |
System of pro-inflammatory cytokines in patients with chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
O. A. Tsevtkova, O. O. Voronkova |
|
Vol 31, No 1 (2021) |
Mechanisms of development of medicine stability Mycobacterium tuberculosis: is there a chance to win? |
Abstract
PDF (Rus)
|
A. G. Naumov, A. V. Pavlunin |
|
No 5 (2004) |
Clarithromycin: the present and the future |
Abstract
PDF (Rus)
|
B. S. Belov |
|
No 4 (2003) |
Risk factors for obstructive sleep disorders development |
Abstract
PDF (Rus)
|
I. M. Voronin, A. M. Belov, A. G. Chuchalin |
|
Vol 32, No 5 (2022) |
The upper respiratory tract microbiome and its role in human health: biotopes and variability |
Abstract
PDF (Rus)
|
E. V. Starikova, Ju. S. Galeeva, E. N. Ilina |
|
No 5 (2002) |
Infectious exacerbation of chronic bronchitis: a choice of optimal antibiotics |
Abstract
PDF (Rus)
|
S. V. Yakovlev, L. I. Dvoretsky |
|
No 1 (2012) |
Future development of therapy with inhaled iloprost in pulmonary arterial hypertension |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
1 - 200 of 467 Items |
1 2 3 > >>
|